In Dispute Over DNA Sequencing ‘Tag’ Technology, Appellants Seek Extension
WASHINGTON, D.C. — A molecular diagnostics company and its subsidiaries deemed liable by a jury for willfully infringing a patented method of preparing nucleic acids say they need more time to...To view the full article, register now.
Already a subscriber? Click here to view full article